Lung Cancer Organizations Join Forces to Launch GO2 Foundation for Lung Cancer
Two nonprofit organizations serving the lung cancer community—the Bonnie J. Addario Lung Cancer Foundation (ALCF) and Lung Cancer Alliance (LCA)—have announced they are joining forces as the GO2 Foundation for Lung Cancer.
With more than 3 decades of combined expertise, a shared “patients-first” philosophy, and complementary programming, the GO2 Foundation for Lung Cancer has launched with principal offices in the San Francisco Bay Area and Washington, DC. The GO2 Foundation will be maximizing resources and staff expertise, integrating and growing networks to reach and support more people, expanding patient-centered research, and amplifying awareness of the steep challenges and needs facing the lung cancer community.
Powerhouse Foundation
“We are thrilled to blend our talent, resources, commitment, and compassion to create this powerhouse foundation,” said Bonnie J. Addario, lung cancer survivor, Co-Founder and Chair of the Board of Directors of the GO2 Foundation for Lung Cancer, and most recently, Founder and Chair of ALCF. “The GO2 Foundation for Lung Cancer will transform what it means to live with lung cancer and increase the patient survival rate of the world’s number one cancer killer annually. Together we will continue to break barriers and save lives.”
“We are on the cusp of early detection and treatment breakthroughs that will forever alter the future of the disease,” said Laurie Fenton Ambrose, Co-Founder, President, and CEO of the GO2 Foundation, and most recently, President and CEO of LCA. “We are seizing this moment to harness this energy and build greater capacity to reach more people with life-saving benefits, personalized care, and comprehensive services that fulfill our credo to ‘Empower Everyone, Ignore No One.’”
GO2 Foundation priorities include:
- Serving the at-risk patient and caregiver communities through professional, credible, free patient support services that include personalized screening, treatment and clinical trial navigation, molecular testing, peer-to-peer mentoring, and support forums
- Advancing academic, community, and patient-centered research that spans the continuum of care for lung cancer detection, treatment, and survivorship
- Directing advocacy action for a health-care system that puts the interests of people first to achieve historic increases in federal research funding, new treatment approvals, and coverage and reimbursement for better access and delivery of care
- Expanding access to excellence in screening, care, treatment, and survivorship across all 50 states to ensure that anyone at risk or diagnosed with lung cancer benefits from life-saving services closer to home.
Challenge Grant
To help launch GO2 Foundation programs, a $15 million challenge grant is being provided in memory of Skip Viragh, a respected and successful financial entrepreneur who inspired those around him to seek innovative solutions and high impact results. This grant—the largest single gift ever for lung cancer—will support GO2 Foundation's vital work to unite a community that empowers people, increases survival, drives innovative research, and changes the future of lung cancer.
For more information, please visit www.go2foundation.org.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
